Adhera Therapeutics Inc
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is… Read more
Adhera Therapeutics Inc (ATRX) - Total Assets
Latest total assets as of September 2023: $44.07K USD
Based on the latest financial reports, Adhera Therapeutics Inc (ATRX) holds total assets worth $44.07K USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Adhera Therapeutics Inc - Total Assets Trend (1986–2022)
This chart illustrates how Adhera Therapeutics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Adhera Therapeutics Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Adhera Therapeutics Inc's total assets of $44.07K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 40.5% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1986–2022)
This chart illustrates how Adhera Therapeutics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Adhera Therapeutics Inc's current assets represent 100.0% of total assets in 2022, an increase from 73.8% in 1986.
- Cash Position: Cash and equivalents constituted 40.5% of total assets in 2022, down from 62.5% in 1986.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1986.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Adhera Therapeutics Inc Competitors by Total Assets
Key competitors of Adhera Therapeutics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Adhera Therapeutics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Adhera Therapeutics Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Adhera Therapeutics Inc generates $ 2977.22 in net profit.
Adhera Therapeutics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.01 | 2.11 |
| Quick Ratio | 0.00 | 0.01 | 2.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-26.32 Million | $ -21.81 Million | $ 2.46 Million |
Adhera Therapeutics Inc - Advanced Valuation Insights
This section examines the relationship between Adhera Therapeutics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -59.7% |
| Total Assets | $79.00K |
| Market Capitalization | $669.77 USD |
Valuation Analysis
Below Book Valuation: The market values Adhera Therapeutics Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Adhera Therapeutics Inc's assets decreased by 59.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Adhera Therapeutics Inc (1986–2022)
The table below shows the annual total assets of Adhera Therapeutics Inc from 1986 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $79.00K | -59.69% |
| 2021-12-31 | $196.00K | +19500.00% |
| 2020-12-31 | $1.00K | -99.76% |
| 2019-12-31 | $420.00K | -91.83% |
| 2018-12-31 | $5.14 Million | -16.87% |
| 2017-12-31 | $6.18 Million | -0.04% |
| 2016-12-31 | $6.19 Million | -18.55% |
| 2015-12-31 | $7.59 Million | -17.59% |
| 2014-12-31 | $9.22 Million | +19.04% |
| 2013-12-31 | $7.74 Million | -34.11% |
| 2012-12-31 | $11.75 Million | -60.09% |
| 2010-12-31 | $29.44 Million | +307.29% |
| 2009-12-31 | $7.23 Million | -44.97% |
| 2008-12-31 | $13.14 Million | -78.68% |
| 2007-12-31 | $61.62 Million | -16.55% |
| 2006-12-31 | $73.83 Million | +1.20% |
| 2005-12-31 | $72.95 Million | -9.68% |
| 2004-12-31 | $80.78 Million | +159.41% |
| 2003-12-31 | $31.14 Million | +35.09% |
| 2002-12-31 | $23.05 Million | +49.29% |
| 2001-12-31 | $15.44 Million | +32.41% |
| 2000-12-31 | $11.66 Million | -42.27% |
| 1999-12-31 | $20.20 Million | -26.55% |
| 1998-12-31 | $27.50 Million | +0.36% |
| 1997-12-31 | $27.40 Million | +112.40% |
| 1996-12-31 | $12.90 Million | +37.23% |
| 1994-12-31 | $9.40 Million | +56.67% |
| 1993-12-31 | $6.00 Million | +700.00% |
| 1992-12-31 | $750.00K | +53.06% |
| 1991-12-31 | $490.00K | -27.94% |
| 1990-12-31 | $680.00K | -12.82% |
| 1989-12-31 | $780.00K | +18.18% |
| 1988-12-31 | $660.00K | +37.50% |
| 1987-12-31 | $480.00K | -40.00% |
| 1986-12-31 | $800.00K | -- |